List View List View   Icon View Icon View

Showing items 1 - 11 of 11.

Add to Quick Collection   All 11 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Title Author/Creator Date Full Text Reviewed
Add Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Cuzick, Jack; Sestak, Ivana; Baum, Michael; Buzdar, Aman; Howell, Anthony... More 2010 — Reviewed
Add Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial Sestak, Ivana; Distler, Wolfgang; Forbes, John F.; Dowsett, Mitch; Howell, Anthony... More 2010 — Reviewed
Add Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen Dowsett, Mitch; Cuzick, Jack; Coombes, Charles; Snowdon, Claire; Gnant, Michael... More 2010 — Reviewed
Add Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC Study Dowsett, Mitch; Cuzick, Jack; Howell, Anthony; Bugarini, Roberto; Baehner, Frederick L.... More 2010 — Reviewed
Add Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial Rabaglio, M.; Sun, Z.; Colleoni, M.; Pienkowski, T.; Nogaret, J. -M.... More 2009 — Reviewed
Add Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-Year update of International Breast Cancer Study Group Trial 11-93 Thürlimann, Beat; Price, Karen N.; Goldhirsch, Aron; Gelber, Richard D.; Holmberg, Stig B.... More 2009 — Reviewed
Add Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists’ Group; Forbes, John F. 2008 — Reviewed
Add Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial Crivellari, Diana; Sun, Zhuoxin; Gelber, Richard D.; Colleoni, Marco; Lang, Istvan... More 2008 — Reviewed
Add Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial Dowsett, Mitch; Allred, Craig; Bishop, Hugh; Ellis, Ian; Larsimont, Danis... More 2008 — Reviewed
Add Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Sestak, Ivana; Cuzick, Jack; Sapunar, Francisco; Eastell, Richard; Forbes, John F.... More 2008 — Reviewed
Add Early stopping of clinical trials (Commentary) Cuzick, J; Howell, A; Forbes, John 2005 —
  • First
  • Previous
  • 1
  • Next
  • Last
Author/Creator
Keyword
Format Type